TVGN
Price:
$0.2985
Market Cap:
$59.31M
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Industry
Biotechnology
IPO Date
2022-01-05
Stock Exchange
NASDAQ
Ticker
TVGN
According to Tevogen Bio Holdings Inc.’s latest financial reports and current stock price. The company's current ROE is 389.21%. This represents a change of 285.26% compared to the average of 101.03% of the last 4 quarters.
The mean historical ROE of Tevogen Bio Holdings Inc. over the last ten years is 74.30%. The current 389.21% ROE has changed 423.84% with respect to the historical average. Over the past ten years (40 quarters), TVGN's ROE was at its highest in in the December 2024 quarter at 138.60%. The ROE was at its lowest in in the March 2023 quarter at -306.17%.
Average
74.30%
Median
79.32%
Minimum
-12.98%
Maximum
151.55%
Discovering the peaks and valleys of Tevogen Bio Holdings Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.63%
Maximum Annual ROE = 151.55%
Minimum Annual Increase = -593.25%
Minimum Annual ROE = -12.98%
| Year | ROE | Change |
|---|---|---|
| 2024 | 151.55% | 136.63% |
| 2023 | 64.05% | -593.25% |
| 2022 | -12.98% | -113.73% |
The current ROE of Tevogen Bio Holdings Inc. (TVGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
67.54%
5-year avg
74.30%
10-year avg
74.30%
Tevogen Bio Holdings Inc.’s ROE is greater than Surrozen, Inc. (-4404.21%), greater than Atossa Therapeutics, Inc. (-49.42%), greater than Cognition Therapeutics, Inc. (-150.10%), greater than Whitehawk Therapeutics Inc (-10.35%), greater than Greenwich LifeSciences, Inc. (-1042.76%), greater than Instil Bio, Inc. (-53.02%), greater than Oncolytics Biotech Inc. (-755.18%), greater than TuHURA Biosciences, Inc. (-325.89%), less than Clene Inc. (351.16%), greater than MacroGenics, Inc. (-98.30%),
| Company | ROE | Market cap |
|---|---|---|
| -4404.21% | $189.26M | |
| -49.42% | $77.50M | |
| -150.10% | $91.24M | |
| -10.35% | $126.78M | |
| -1042.76% | $415.91M | |
| -53.02% | $48.83M | |
| -755.18% | $101.36M | |
| -325.89% | $31.68M | |
| 351.16% | $38.80M | |
| -98.30% | $122.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tevogen Bio Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tevogen Bio Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tevogen Bio Holdings Inc.'s ROE?
How is the ROE calculated for Tevogen Bio Holdings Inc. (TVGN)?
What is the highest ROE for Tevogen Bio Holdings Inc. (TVGN)?
What is the 3-year average ROE for Tevogen Bio Holdings Inc. (TVGN)?
What is the 5-year average ROE for Tevogen Bio Holdings Inc. (TVGN)?
How does the current ROE for Tevogen Bio Holdings Inc. (TVGN) compare to its historical average?